Breaking News Instant updates and real-time market news.

KDMN

Kadmon

$4.15 /

-0.115 (-2.70%)

08:32
09/08/20
09/08
08:32
09/08/20
08:32

Kadmon granted ODD from FDA for belumosudil

Kadmon Holdings said in a release, "Kadmon Holdings announced that the FDA has granted Orphan Drug Designation, or ODD, to belumosudil (KD025), the Company's Rho-associated coiled-coil kinase 2 (ROCK2) inhibitor, for the treatment of systemic sclerosis (SSc). SSc is a chronic immune disorder characterized by fibrosis of the skin and internal organs, affecting approximately 75,000 to 100,000 people in the United States. Belumosudil is being studied in an ongoing double-blind, placebo-controlled Phase 2 clinical trial in adults with SSc. The study is enrolling 60 patients to receive belumosudil 200 mg QD, belumosudil 200 mg BID or placebo for 24 weeks. In addition, the Company plans to initiate a small (12-15 patient), open-label Phase 2 clinical trial of belumosudil in patients with diffuse cutaneous systemic sclerosis in Q1 2021. Belumosudil is also being developed for the treatment of chronic graft-versus-host disease (cGVHD), a complication following hematopoietic cell transplantation that leads to inflammation and fibrosis in multiple tissues. Kadmon expects to submit a New Drug Application for belumosudil in cGVHD in the fourth quarter of 2020."

  • 14

    Nov

KDMN Kadmon
$4.15 /

-0.115 (-2.70%)

08/17/20
Loeb's Third Point buys Alibaba, makes a top holding, during second quarter
05/19/20 Raymond James
Kadmon initiated with an Outperform at Raymond Jame
05/19/20 Raymond James
Kadmon initiated with an Outperform at Raymond James
03/16/20 Nomura Instinet
Kadmon news of FDA meeting a positive, says Nomura Instinet

TODAY'S FREE FLY STORIES

Syndicate
Taysha Gene Therapies 7.87M share IPO priced at $20.00 » 07:02
09/24/20
09/24
07:02
09/24/20
07:02
TSHA

Taysha Gene Therapies

$0.00 /

+ (+0.00%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 24
    Sep
TSHA Taysha Gene Therapies
$0.00 /

+ (+0.00%)

Hot Stocks
Darden reinstates quarterly dividend of 30c per share » 07:02
09/24/20
09/24
07:02
09/24/20
07:02
DRI

Darden

$89.94 /

-0.02 (-0.02%)

The dividend is payable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

09/22/20 Oppenheimer
Darden price target raised to $100 from $90 at Oppenheimer
09/21/20
Fly Intel: Top five analyst downgrades
09/21/20 Stephens
Stephens says Darden still a top pick, expects in-line Q1 comps
09/21/20 RBC Capital
Darden price target raised to $97 from $86 at RBC Capital
DRI Darden
$89.94 /

-0.02 (-0.02%)

  • 21
    Apr
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

Hot Stocks
Darden reports Q1 blended same-restaurant sales down 29%  07:01
09/24/20
09/24
07:01
09/24/20
07:01
DRI

Darden

$89.94 /

-0.02 (-0.02%)

 
ShowHide Related Items >><<
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

09/22/20 Oppenheimer
Darden price target raised to $100 from $90 at Oppenheimer
09/21/20
Fly Intel: Top five analyst downgrades
09/21/20 Stephens
Stephens says Darden still a top pick, expects in-line Q1 comps
09/21/20 RBC Capital
Darden price target raised to $97 from $86 at RBC Capital
DRI Darden
$89.94 /

-0.02 (-0.02%)

  • 21
    Apr
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

Earnings
Darden reports Q1 adjusted cont ops EPS 56c, consensus 5c » 07:00
09/24/20
09/24
07:00
09/24/20
07:00
DRI

Darden

$89.94 /

-0.02 (-0.02%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

09/22/20 Oppenheimer
Darden price target raised to $100 from $90 at Oppenheimer
09/21/20
Fly Intel: Top five analyst downgrades
09/21/20 Stephens
Stephens says Darden still a top pick, expects in-line Q1 comps
09/21/20 RBC Capital
Darden price target raised to $97 from $86 at RBC Capital
DRI Darden
$89.94 /

-0.02 (-0.02%)

  • 21
    Apr
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

Recommendations
Durect study designed to support full approval, says H.C. Wainwright » 06:59
09/24/20
09/24
06:59
09/24/20
06:59
DRRX

Durect

$1.69 /

-0.07 (-3.98%)

, GILD

Gilead

$63.10 /

-0.29 (-0.46%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DRRX Durect
$1.69 /

-0.07 (-3.98%)

GILD Gilead
$63.10 /

-0.29 (-0.46%)

DRRX Durect
$1.69 /

-0.07 (-3.98%)

07/30/20 Oppenheimer
Durect initiated with an Outperform at Oppenheimer
07/01/20 H.C. Wainwright
Durect alcoholic hepatitis efficacy could be seen in COVID, says H.C. Wainwright
06/29/20 B. Riley FBR
Durect should be bought on weakness from Gilead termination, says B. Riley FBR
06/29/20 H.C. Wainwright
Durect thesis unchanged after Gilead termination, says H.C. Wainwright
GILD Gilead
$63.10 /

-0.29 (-0.46%)

09/20/20 Citi
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi
09/18/20 RBC Capital
Gilead price target raised to $86 from $82 at RBC Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 Maxim
Gilead upgraded to Buy at Maxim following Immunomedics deal
DRRX Durect
$1.69 /

-0.07 (-3.98%)

GILD Gilead
$63.10 /

-0.29 (-0.46%)

GILD Gilead
$63.10 /

-0.29 (-0.46%)

DRRX Durect
$1.69 /

-0.07 (-3.98%)

GILD Gilead
$63.10 /

-0.29 (-0.46%)

DRRX Durect
$1.69 /

-0.07 (-3.98%)

GILD Gilead
$63.10 /

-0.29 (-0.46%)

Initiation
Ingersoll-Rand initiated with a Buy at Jefferies » 06:58
09/24/20
09/24
06:58
09/24/20
06:58
IR

Ingersoll-Rand

$35.02 /

-0.07 (-0.20%)

Jefferies analyst Stephen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IR Ingersoll-Rand
$35.02 /

-0.07 (-0.20%)

IR Ingersoll-Rand
$35.02 /

-0.07 (-0.20%)

07/13/20 Morgan Stanley
Illinois Tool Works downgraded to Underweight at Morgan Stanley
06/14/20 Goldman Sachs
Ingersoll-Rand reinstated with a Neutral at Goldman Sachs
05/13/20
Fly Intel: Top five analyst downgrades
05/13/20 Baird
Ingersoll-Rand long-term thesis remain intact, says Baird
IR Ingersoll-Rand
$35.02 /

-0.07 (-0.20%)

  • 17
    Jun
IR Ingersoll-Rand
$35.02 /

-0.07 (-0.20%)

Hot Stocks
Bausch Health announces Vyzulta approval in Ukraine » 06:57
09/24/20
09/24
06:57
09/24/20
06:57
BHC

Bausch Health

$15.75 /

-0.3 (-1.87%)

Bausch Health, Bausch +…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHC Bausch Health
$15.75 /

-0.3 (-1.87%)

BHC Bausch Health
$15.75 /

-0.3 (-1.87%)

09/17/20
Fly Intel: Top five analyst upgrades
09/17/20 BofA
Bausch Health upgraded to Neutral from Underperform at BofA
08/24/20 JPMorgan
Bausch Health shares can double into separation, says JPMorgan
08/24/20 H.C. Wainwright
Bausch Health price target lowered to $50 from $64 at H.C. Wainwright
BHC Bausch Health
$15.75 /

-0.3 (-1.87%)

BHC Bausch Health
$15.75 /

-0.3 (-1.87%)

BHC Bausch Health
$15.75 /

-0.3 (-1.87%)

Hot Stocks
Accenture sees FY21 operating cash flow $6.35B-$6.85B » 06:57
09/24/20
09/24
06:57
09/24/20
06:57
ACN

Accenture

$230.61 /

-6.11 (-2.58%)

Sees FY21 free cash flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

09/22/20 UBS
Accenture assumed with a Neutral at UBS
09/22/20 Wedbush
Accenture price target raised to $255 from $240 at Wedbush
09/22/20 Piper Sandler
Accenture price target raised to $229 from $206 at Piper Sandler
09/21/20 BMO Capital
Accenture price target raised to $255 from $215 at BMO Capital
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

Hot Stocks
Accenture reports Q4 new bookings $14B  06:56
09/24/20
09/24
06:56
09/24/20
06:56
ACN

Accenture

$230.61 /

-6.11 (-2.58%)

 
ShowHide Related Items >><<
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

09/22/20 UBS
Accenture assumed with a Neutral at UBS
09/22/20 Wedbush
Accenture price target raised to $255 from $240 at Wedbush
09/22/20 Piper Sandler
Accenture price target raised to $229 from $206 at Piper Sandler
09/21/20 BMO Capital
Accenture price target raised to $255 from $215 at BMO Capital
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

Syndicate
Penn National files to sell 14M shares of common stock » 06:55
09/24/20
09/24
06:55
09/24/20
06:55
PENN

Penn National

$69.10 /

-5.24 (-7.05%)

Goldman Sachs & Co.,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PENN Penn National
$69.10 /

-5.24 (-7.05%)

PENN Penn National
$69.10 /

-5.24 (-7.05%)

06:17 Today Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
06:05 Today Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
09/22/20 Morgan Stanley
Barstool Sportsbook app 'bullish' for the sector, says Morgan Stanley
09/17/20 Stifel
Penn National price target raised to $85 from $47 at Stifel
PENN Penn National
$69.10 /

-5.24 (-7.05%)

  • 12
    May
PENN Penn National
$69.10 /

-5.24 (-7.05%)

PENN Penn National
$69.10 /

-5.24 (-7.05%)

PENN Penn National
$69.10 /

-5.24 (-7.05%)

Initiation
Tencent Music initiated with a Buy at Needham » 06:55
09/24/20
09/24
06:55
09/24/20
06:55
TME

Tencent Music

$14.73 /

-0.2 (-1.34%)

Needham analyst Vincent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TME Tencent Music
$14.73 /

-0.2 (-1.34%)

TME Tencent Music
$14.73 /

-0.2 (-1.34%)

08/14/20
Tencent Music upgraded to Outperform from Perform at Oppenheimer
08/14/20 Oppenheimer
Tencent Music upgraded to Outperform from Perform at Oppenheimer
06/30/20 UBS
Tencent Music upgraded to Buy from Neutral at UBS
06/30/20 Citi
Tencent Music initiated with a Buy at Citi
TME Tencent Music
$14.73 /

-0.2 (-1.34%)

TME Tencent Music
$14.73 /

-0.2 (-1.34%)

TME Tencent Music
$14.73 /

-0.2 (-1.34%)

Hot Stocks
CarMax plans to open 8-10 stores in FY22  06:53
09/24/20
09/24
06:53
09/24/20
06:53
KMX

CarMax

$105.98 /

+1.645 (+1.58%)

 
ShowHide Related Items >><<
KMX CarMax
$105.98 /

+1.645 (+1.58%)

KMX CarMax
$105.98 /

+1.645 (+1.58%)

09/22/20 RBC Capital
CarMax price target raised to $110 from $100 at RBC Capital
08/18/20 Wedbush
CarMax price target raised to $120 from $100 at Wedbush
08/12/20 Guggenheim
CarMax price target raised to $114 from $106 at Guggenheim
07/02/20 Oppenheimer
CarMax price target raised to $108 from $87 at Oppenheimer
KMX CarMax
$105.98 /

+1.645 (+1.58%)

KMX CarMax
$105.98 /

+1.645 (+1.58%)

KMX CarMax
$105.98 /

+1.645 (+1.58%)

KMX CarMax
$105.98 /

+1.645 (+1.58%)

Recommendations
AMD PC share gains continue, says Susquehanna » 06:53
09/24/20
09/24
06:53
09/24/20
06:53
AMD

AMD

$74.72 /

-2.98 (-3.84%)

Susquehanna analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMD AMD
$74.72 /

-2.98 (-3.84%)

AMD AMD
$74.72 /

-2.98 (-3.84%)

09/18/20 Northland
Combined Nvidia-ARM a long-term risk for AMD, Intel and Vicor, says Northland
09/09/20 Lynx
Lynx raises outlook for AMD to a $110B market cap, price expectation in the $90s
09/02/20 Wells Fargo
New processors should make Intel more competitive with AMD, says Wells Fargo
09/02/20 Goldman Sachs
Nvidia price target raised to $585 from $528 at Goldman Sachs
AMD AMD
$74.72 /

-2.98 (-3.84%)

AMD AMD
$74.72 /

-2.98 (-3.84%)

AMD AMD
$74.72 /

-2.98 (-3.84%)

AMD AMD
$74.72 /

-2.98 (-3.84%)

Earnings
CarMax reports Q2 EPS $1.79, consensus $1.08 » 06:52
09/24/20
09/24
06:52
09/24/20
06:52
KMX

CarMax

$105.98 /

+1.645 (+1.58%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KMX CarMax
$105.98 /

+1.645 (+1.58%)

KMX CarMax
$105.98 /

+1.645 (+1.58%)

09/22/20 RBC Capital
CarMax price target raised to $110 from $100 at RBC Capital
08/18/20 Wedbush
CarMax price target raised to $120 from $100 at Wedbush
08/12/20 Guggenheim
CarMax price target raised to $114 from $106 at Guggenheim
07/02/20 Oppenheimer
CarMax price target raised to $108 from $87 at Oppenheimer
KMX CarMax
$105.98 /

+1.645 (+1.58%)

KMX CarMax
$105.98 /

+1.645 (+1.58%)

KMX CarMax
$105.98 /

+1.645 (+1.58%)

KMX CarMax
$105.98 /

+1.645 (+1.58%)

Hot Stocks
Eagle Pharmaceuticals commences $25M accelerated share repurchase » 06:52
09/24/20
09/24
06:52
09/24/20
06:52
EGRX

Eagle Pharmaceuticals

$39.54 /

-0.19 (-0.48%)

Eagle Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EGRX Eagle Pharmaceuticals
$39.54 /

-0.19 (-0.48%)

EGRX Eagle Pharmaceuticals
$39.54 /

-0.19 (-0.48%)

Hot Stocks
Accenture raises quarterly dividend 10%, approves $5B share repurchase » 06:50
09/24/20
09/24
06:50
09/24/20
06:50
ACN

Accenture

$230.61 /

-6.11 (-2.58%)

Accenture plc has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

09/22/20 UBS
Accenture assumed with a Neutral at UBS
09/22/20 Wedbush
Accenture price target raised to $255 from $240 at Wedbush
09/22/20 Piper Sandler
Accenture price target raised to $229 from $206 at Piper Sandler
09/21/20 BMO Capital
Accenture price target raised to $255 from $215 at BMO Capital
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

Recommendations
Scientific Games price target raised to $29 from $20 at Macquarie » 06:50
09/24/20
09/24
06:50
09/24/20
06:50
SGMS

Scientific Games

$30.40 /

-3.39 (-10.03%)

Macquarie analyst Chad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGMS Scientific Games
$30.40 /

-3.39 (-10.03%)

SGMS Scientific Games
$30.40 /

-3.39 (-10.03%)

09/21/20
Fly Intel: Top five analyst upgrades
09/21/20 Jefferies
Jefferies upgrades Scientific Games to Buy, raises price target to $50 from $20
09/21/20 Jefferies
Scientific Games upgraded to Buy from Hold at Jefferies
08/31/20 Jefferies
After recent filing, Jefferies says 'something happening' at Scientific Games
SGMS Scientific Games
$30.40 /

-3.39 (-10.03%)

SGMS Scientific Games
$30.40 /

-3.39 (-10.03%)

SGMS Scientific Games
$30.40 /

-3.39 (-10.03%)

Recommendations
International Game price target raised to $16 from $15 at Macquarie » 06:49
09/24/20
09/24
06:49
09/24/20
06:49
IGT

International Game

$10.95 /

-1.01 (-8.44%)

Macquarie analyst Chad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IGT International Game
$10.95 /

-1.01 (-8.44%)

IGT International Game
$10.95 /

-1.01 (-8.44%)

08/07/20 Susquehanna
International Game downgraded to Neutral from Positive at Susquehanna
08/04/20 Deutsche Bank
International Game post earnings selloff 'illogical,' says Deutsche Bank
05/21/20
Fly Intel: Top five analyst downgrades
05/21/20 Societe Generale
International Game downgraded to Hold on 'long' recovery at Societe Generale
IGT International Game
$10.95 /

-1.01 (-8.44%)

IGT International Game
$10.95 /

-1.01 (-8.44%)

Hot Stocks
Comscore announces renewal agreement with Graham Media Group » 06:49
09/24/20
09/24
06:49
09/24/20
06:49
SCOR

Comscore

$2.00 /

-0.08 (-3.85%)

Comscore announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCOR Comscore
$2.00 /

-0.08 (-3.85%)

SCOR Comscore
$2.00 /

-0.08 (-3.85%)

08/19/20 Truist
Comscore most likely to remain independent, says Truist
SCOR Comscore
$2.00 /

-0.08 (-3.85%)

SCOR Comscore
$2.00 /

-0.08 (-3.85%)

Recommendations
MGM Resorts price target raised to $30 from $27 at Macquarie » 06:48
09/24/20
09/24
06:48
09/24/20
06:48
MGM

MGM Resorts

$21.38 /

-0.25 (-1.16%)

Macquarie analyst Chan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGM MGM Resorts
$21.38 /

-0.25 (-1.16%)

MGM MGM Resorts
$21.38 /

-0.25 (-1.16%)

09/16/20
Fly Intel: Top five analyst downgrades
09/16/20 Roth Capital
MGM Resorts downgraded to Neutral from Buy at Roth Capital
09/14/20
Fly Intel: Top five analyst downgrades
09/14/20 Goldman Sachs
MGM Resorts downgraded to Sell from Neutral at Goldman Sachs
MGM MGM Resorts
$21.38 /

-0.25 (-1.16%)

MGM MGM Resorts
$21.38 /

-0.25 (-1.16%)

MGM MGM Resorts
$21.38 /

-0.25 (-1.16%)

MGM MGM Resorts
$21.38 /

-0.25 (-1.16%)

Hot Stocks
Bank of America names Lionel Nowell Lead Independent Director successor » 06:48
09/24/20
09/24
06:48
09/24/20
06:48
BAC

Bank of America

$23.27 /

-0.675 (-2.82%)

Bank of America announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAC Bank of America
$23.27 /

-0.675 (-2.82%)

BAC Bank of America
$23.27 /

-0.675 (-2.82%)

09/03/20 Deutsche Bank
Bank of America upgraded to Buy from Hold at Deutsche Bank
07/09/20 DA Davidson
Bank of America downgraded to Neutral from Buy at DA Davidson
07/08/20
Fly Intel: Top five analyst initiations
07/08/20 Seaport Global
Bank of America initiated with a Neutral at Seaport Global
BAC Bank of America
$23.27 /

-0.675 (-2.82%)

BAC Bank of America
$23.27 /

-0.675 (-2.82%)

BAC Bank of America
$23.27 /

-0.675 (-2.82%)

BAC Bank of America
$23.27 /

-0.675 (-2.82%)

Earnings
Owens & Minor raises FY20 adjusted EPS view to $1.75-$1.90 from $1.00-$1.20 » 06:48
09/24/20
09/24
06:48
09/24/20
06:48
OMI

Owens & Minor

$13.80 /

-0.49 (-3.43%)

Consensus is $1.08. The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OMI Owens & Minor
$13.80 /

-0.49 (-3.43%)

OMI Owens & Minor
$13.80 /

-0.49 (-3.43%)

08/11/20 Baird
Baird names Owens & Minor as Fresh Pick, sees 'unusual opportunity'
07/22/20 Baird
Owens & Minor upgraded to Outperform from Neutral at Baird
07/21/20 Baird
Owens & Minor upgraded to Outperform from Neutral at Baird
07/21/20 BofA
Owens & Minor upgraded to Buy at BofA after pre-announcement
OMI Owens & Minor
$13.80 /

-0.49 (-3.43%)

OMI Owens & Minor
$13.80 /

-0.49 (-3.43%)

OMI Owens & Minor
$13.80 /

-0.49 (-3.43%)

OMI Owens & Minor
$13.80 /

-0.49 (-3.43%)

Recommendations
Cintas price target raised to $323 from $288 at Stifel » 06:48
09/24/20
09/24
06:48
09/24/20
06:48
CTAS

Cintas

/

+

Stifel analyst Shlomo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTAS Cintas
/

+

CTAS Cintas
/

+

06:43 Today Baird
Cintas good news increasingly priced in to shares, says Baird
06:34 Today RBC Capital
Cintas price target raised to $360 from $347 at RBC Capital
09/18/20 Baird
Cintas designated a Fresh Pick into earnings,at Baird
07/24/20 RBC Capital
Cintas price target raised to $347 from $318 at RBC Capital
CTAS Cintas
/

+

CTAS Cintas
/

+

CTAS Cintas
/

+

Recommendations
Boyd Gaming price target raised to $35 from $33 at Macquarie » 06:48
09/24/20
09/24
06:48
09/24/20
06:48
BYD

Boyd Gaming

$27.67 /

-1.05 (-3.66%)

Macquarie analyst Chad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BYD Boyd Gaming
$27.67 /

-1.05 (-3.66%)

BYD Boyd Gaming
$27.67 /

-1.05 (-3.66%)

09/09/20 JPMorgan
Boyd Gaming price target raised to $40 from $30 at JPMorgan
08/28/20 Union Gaming
Boyd Gaming upgraded to Buy from Hold at Union Gaming
07/29/20 JPMorgan
Boyd Gaming price target raised to $30 from $24 at JPMorgan
07/29/20 Deutsche Bank
Boyd Gaming price target raised to $27 from $22 at Deutsche Bank
BYD Boyd Gaming
$27.67 /

-1.05 (-3.66%)

BYD Boyd Gaming
$27.67 /

-1.05 (-3.66%)

BYD Boyd Gaming
$27.67 /

-1.05 (-3.66%)

BYD Boyd Gaming
$27.67 /

-1.05 (-3.66%)

Earnings
Accenture sees Q1 revenue $11.15B- $11.55B, consensus $11.52B » 06:47
09/24/20
09/24
06:47
09/24/20
06:47
ACN

Accenture

$230.61 /

-6.11 (-2.58%)

The company is assuming a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

09/22/20 UBS
Accenture assumed with a Neutral at UBS
09/22/20 Wedbush
Accenture price target raised to $255 from $240 at Wedbush
09/22/20 Piper Sandler
Accenture price target raised to $229 from $206 at Piper Sandler
09/21/20 BMO Capital
Accenture price target raised to $255 from $215 at BMO Capital
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.